...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >MYELODYSPLASTIC SYNDROME FOLLOWING ESSENTIAL THROMBOCYTOPENIA IN HYPERTENSION -- A CASE REPORT
【24h】

MYELODYSPLASTIC SYNDROME FOLLOWING ESSENTIAL THROMBOCYTOPENIA IN HYPERTENSION -- A CASE REPORT

机译:高血压后实质性血小板减少症后的骨髓增生异常综合征-病例报告

获取原文
           

摘要

Myelodysplastic Syndrome (MDS) is a disorder of haemopoietic stem cell. Since, it has not been commonly observed in Pakistan, thus, this case study is to understand the scientific and therapeutical comprehension of MDS. An 81 year old male hypertensive patient was presented in a private hospital of Islamabad, Pakistan, with anemia. On medical investigation the physician prescribed him, multi-vitamins OD for a month; injection G-CSF 300mcg once a week; Molgramostim 300μg on every alternate day for 3 weeks; T halidomide 100mg OD with Alprazolam 0.5mg at night for 4 weeks and 5'-azacytidine for a month. Clinical and pharmaceutical inaccuracies were observed. Moreover; the high cost and long term therapy are major obstacles to cure this disease. Therefore, affordable method and short-term effective therapy and reduced cost of drugs will help to cure the disease in more efficient way and in less time with more promising results
机译:骨髓增生异常综合症(MDS)是造血干细胞疾病。由于在巴基斯坦尚未普遍观察到这种情况,因此,本案例研究旨在了解MDS的科学和治疗意义。一名81岁的男性高血压患者在巴基斯坦伊斯兰堡一家私立医院接受治疗,患有贫血。经医学检查,医生为他开了一个月的多种维生素OD。每周一次注射G-CSF 300mcg;莫格莫司汀300μg,隔3天一次;沙利度胺100mg OD,阿普唑仑0.5mg,晚上4周,5'-氮杂胞苷一个月。观察到临床和药物上的不准确性。此外;高成本和长期治疗是治愈该疾病的主要障碍。因此,负担得起的方法和短期有效的治疗方法以及降低的药物成本将有助于以更有效的方式,更短的时间治愈疾病,并获得更可喜的结果

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号